STAKEHOLDERS MEETING FOR PRIORITY MEDICINES

FOR EUROPE AND THE WORLD

Permanent Representation of the Netherlands to the EU

Hermann Debrouxlaan 48, Brussels , Belgium

 Monday 4 October 2004

09:00

Welcome

 

Herman van der Plas (First Secretary on Research)
Hans Hogerzeil (WHO)

09:05

Introduction to the day's programme

 

Bert Leufkens (Utrecht University for Pharmaceutical Sciences)

09:10

Priority Medicines Project Overview

 

Bart Wijnberg (Ministry of Public Health, Welfare and Sport)

09:30

Chapters 1-5 of report including
Priority Setting, Methods & Results

[204KB]

Richard Laing & Warren Kaplan (WHO)

 

Imagine a world without antibiotics

[40MB]

 

10:45

Antibacterial Drug Resistance

[24MB]

Otto Cars (Swedish Institute for Infectious Disease Control) and Dominique Monnet (Statens Serum Institute)

11:15

Pandemic Influenza

[1MB]

Anna Lönnroth (European Commission DG-Research)

11:45

Cardiovascular Disease

[185KB]

Shanthi Mendis (WHO)

12:15

Tuberculosis

[461KB]

Mary Moran (London School of Economics)

14:00

Acute Stroke and Alzheimer Disease

[3MB]

Jackie Hunter (GSK)

14:30

Neglected Diseases

[18MB]

Ellen 't Hoen (Médecins Sans Frontières)

15:00

Cross Cutting Themes (Chapter 7)

[60KB]

Bert Leufkens, Warren Kaplan

15:45

Public-Private Partnerships

[1.2MB]

Frans van den Boom (International AIDS Vaccines Initiative)

16:15

Barriers to Innovation & Comparative Trials

[56KB]

Richard Laing and Warren Kaplan (WHO)

16:45

Determining value for Innovation

[250KB]

Richard Laing (WHO)

17:15

Concluding remarks

 

Marianne Takki (European Commission DG-SANCO)

Thomas Heynisch (DG-Enterprise)
Arnd Hoeveler (DG-Research)

17:30

Closure

 

Bert Leufkens